Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Mutaflor (Escherichia coli strain Nissle 1917) |
?
The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. Biochemical pharmacology (Biochem Pharmacol ) Vol: 82 Issue 12 Pages: 1891-900 Pub: 2011 Dec 15 Epub: 2011 Sep 16 Authors Garrido-Mesa N , Utrilla P , Comalada M , Zorrilla P , Garrido-Mesa J , Zarzuelo A , Rodríguez-Cabezas ME , Gálvez J , Publication |
Mutaflor (Escherichia coli strain Nissle 1917) |
?
Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4. Pathogens and disease (Pathog Dis ) Vol: 70 Issue 3 Pages: 390-400 Pub: 2014 Apr Epub: 2014 Mar 11 Authors Jiang Y , Kong Q , Roland KL , Wolf A , Curtiss R 3rd , Html Article Publication |
Mutaflor (Escherichia coli strain Nissle 1917) |
?
Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection. Infection and immunity (Infect Immun ) Vol: 82 Issue 5 Pages: 1801-12 Pub: 2014 May Epub: 2014 Feb 18 Authors Kleta S , Nordhoff M , Tedin K , Wieler LH , Kolenda R , Oswald S , Oelschlaeger TA , Bleiss W , Schierack P , Html Article Publication |
Mutaflor (Escherichia coli strain Nissle 1917) |
?
Insights from 100 Years of Research with Probiotic E. Coli European Journal of Microbiology & Immunology (Eur J Microbiol Immunol (Bp) ) Vol: 6 Issue 3 Pages: 147-161 Pub: 2016 Sep 29 Epub: 2016 Sep 29 Authors Wassenaar TM , Html Article Publication |
Mutaflor (Escherichia coli strain Nissle 1917) |
?
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal immunology (Mucosal Immunol ) Vol: 2 Issue 2 Pages: 166-72 Pub: 2009 Mar Epub: 2008 Nov 26 Authors Möndel M , Schroeder BO , Zimmermann K , Huber H , Nuding S , Beisner J , Fellermann K , Stange EF , Wehkamp J , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.